Fund Name | Location |
Archipelago | California, Mill Valley, United States |
Blue Haven Initiative | Cambridge, Massachusetts, United States |
ECCO | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
Finistere Ventures | California, San Diego, United States |
FWD Fuji Life Insurance | Japan, Tokyo |
GDP Venture | Indonesia, Jakarta, Jakarta Raya |
Greenstart | California, San Francisco, United States |
Hengfeng Guoji | China, Hangzhou, Zhejiang |
KPN | Rotterdam, The Netherlands, Zuid-Holland |
Maryland Health Care Product Development | Maryland, Rockville, United States |
Meihe Touzi | Beijing, China, Shijingshan |
Mid-Atlantic Angel Group | Pennsylvania, Philadelphia, United States |
MizMaa Ventures | Israel, Tel Aviv, Tel Aviv |
Neoteny 4 | - |
Newcastle Science City | Newcastle upon Tyne, North East, United Kingdom |
PA Consulting Group | England, London, United Kingdom |
SeaX Ventures | California, San Francisco, United States |
Sinuo Chengzhang Investment Management | Beijing, Beijing, China |
SparkChain Capital | California, Palo Alto, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Figure | $675M | 24 Feb 2024 | Sunnyvale, California, United States | ||
Figure | $675M | 23 Feb 2024 | Sunnyvale, California, United States | ||
Persefoni | $50M | 11 Aug 2023 | Tempe, Arizona, United States | ||
Figure | $70M | 19 Apr 2023 | Sunnyvale, California, United States | ||
OXOS Medical | $23M | 05 Apr 2023 | Atlanta, Georgia, United States | ||
Gemba | $18M | 25 Jan 2023 | London, England, United Kingdom | ||
TestFit | $20M | 15 Jul 2022 | Dallas, Texas, United States | ||
Cleared | 01 Jan 2022 | New York, New York, United States | |||
SIERA.AI | $6M | 03 Nov 2021 | Austin, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Figure | $675M | 24 Feb 2024 | Sunnyvale, California, United States | ||
Figure | $675M | 23 Feb 2024 | Sunnyvale, California, United States | ||
Persefoni | $50M | 11 Aug 2023 | Tempe, Arizona, United States | ||
Figure | $70M | 19 Apr 2023 | Sunnyvale, California, United States | ||
OXOS Medical | $23M | 05 Apr 2023 | Atlanta, Georgia, United States | ||
Gemba | $18M | 25 Jan 2023 | London, England, United Kingdom | ||
TestFit | $20M | 15 Jul 2022 | Dallas, Texas, United States | ||
Cleared | 01 Jan 2022 | New York, New York, United States | |||
SIERA.AI | $6M | 03 Nov 2021 | Austin, Texas, United States |